Physician profile
Scott V Joy
NPI 1144304205
$27,302.37
in general payments reported to CMS, 2019-2025
21 companies · $23K in 2025
The $23K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.60 · 2023: $2,671 · 2024: $1,160 · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,800 · Honoraria: $7,700 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,775 · Travel and Lodging: $2,756 · Food and Beverage: $1,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,800.00 |
| Honoraria | $7,700.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,774.50 |
| Travel and Lodging | $2,755.94 |
| Food and Beverage | $1,222.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $11,095.67 | 2024-2025 | Kisunla |
| Axsome Therapeutics, INC. | $9,143.09 | 2025 | |
| Pfizer INC. | $3,036.44 | 2023-2025 | |
| Eli Lilly and Company | $2,850.00 | 2025 | Kisunla |
| Eko Health, INC. | $500.00 | 2024 | |
| Heartflow, INC. | $155.97 | 2025 | |
| Glaxosmithkline, LLC. | $126.24 | 2023-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $69.35 | 2025 | Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $49.60 | 2019 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $27.37 | 2025 | Rexulti |
| Astellas Pharma US INC | $26.71 | 2025 | Veozah |
| Hologic Sales and Service, LLC | $26.41 | 2025 | Thinprep 2000 Processor, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $26.12 | 2025 | |
| Abbvie INC. | $24.28 | 2025 | |
| Amneal Pharmaceuticals LLC | $23.54 | 2025 | Unithroid |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $23.01 | 2025 | |
| Amgen INC. | $21.92 | 2023 | Repatha, Otezla |
| Sonex Health, INC. | $21.85 | 2025 | Sx-One Microknife |
| Dexcom, INC. | $21.02 | 2023 | Dexcom G6 Transmitter |
| Medtronic, INC. | $17.57 | 2024 | Corevalve Evolut R |
| Exeltis, USA INC. | $16.21 | 2023 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Joy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.